Pharmavite appoints Jeff Boutelle as new CEO

By Adi Menayang

- Last updated on GMT

Pharmavite appoints Jeff Boutelle as new CEO

Related tags Chief executive officer

US manufacturer Pharmavite LLC, announced Jeff Boutelle as its new Chief Executive Officer and board member, effective August 7. Noriko Tojo, Pharmavite's current CEO will continue to serve as chair of Pharmavite's board and CEO of Otsuka Medical Devices.

"Jeff's business experience and leadership abilities are fully aligned with Pharmavite's mission, vision and culture,"​ said Tojo.

"He is an accomplished consumer products goods chief executive, with extensive global experience. His career spans numerous well-regarded companies, including Abbott, Nestle, Procter & Gamble and most recently Beech-Nut Nutrition where, as CEO, he led a reinvention of their baby food business."

Boutelle has worked on brands such as Similac, Pediasure, Pedialyte, Stouffers, Pampers, and Beech-Nut. He believes that to win in the marketplace, deep consumer understanding and insight to reveal and meet consumer needs is imperative. Globally, his general management and brand responsibilities have encompassed 40+ countries across Europe, the Middle East and Africa.

"I'm incredibly excited to join the Pharmavite team,"​ said Boutelle. "Pharmavite has that rare combination of leading products, talented people, and momentum in the market. Now more than ever, the dietary supplement industry is evolving at a rapid pace, and I look forward to the many opportunities ahead to continue to grow and lead this category as Pharmavite's CEO."

Boutelle holds a Bachelor of Science in Accounting and Management Information Systems from Bowling Green State University, and received a Master of Business Administration from Duke University. 

Related topics People

Related news

Show more

Follow us


View more